Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
William Meury Insider Profile
4 Followers
William Meury, EVP & CCO at Allergan, holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX), holds 65.00K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 0.00 shares in Allergan (Ticker: AGN).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-7.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that William Meury holds in companies
Most Profitable Insider Trade
The most profitable trade made by William Meury
William Meury's Trading History
Allergan
May 11, 2020
―
Uninformative Sell
―
$0.00
Syndax Pharmaceuticals
Feb 09, 2024
Director
Uninformative Buy
―
$1.36M
Karuna Therapeutics
Mar 18, 2024
―
Uninformative Sell
9.70M
$0.00
Forest Labs
Jul 03, 2014
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see William Meury's performance on stock
You May Also Like
William Meury insider profile FAQ
What is the percentage of profitable transactions made by William Meury?
The percentage of profitable transactions made by William Meury is 0%.
What is the average return per transaction made by William Meury?
The average return per transaction made by William Meury is -7.10%.
What stocks does William Meury hold?
William Meury holds: AGN, SNDX, KRTX, ~FRX stocks.
What was William Meury’s latest transaction?
William Meury latest transaction was an Uninformative Sell of $9.70M.
What was William Meury's most profitable transaction?
William Meury’s most profitable transaction was an Informative Sell of SNDX stock on August 3, 2023. The return on the trade was -2.20%.
What is William Meury's role in Allergan?
William Meury's role in Allergan is EVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.